Device Trial Radar · NCT06424977
Biomarker Targeted Stimulation for Epileptiform Events
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Nov 1, 2026
Primary completion
May 1, 2028
Study completion Nov 1, 2030
Sponsor
- Lead sponsor
- Cadence NeuroscienceNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 22, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Male only, from 7 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, prospective, controlled study designed to evaluate treatment with the BTS System.
Conditions
- Epilepsy
Interventions
Biomarker Targeted Stimulation (BTS)Device
Using continuous stimulation to target multiple network nodes, Biomarker Targeted Stimulation (BTS) is intended to suppress abnormal interictal activity, as determined by biomarkers including interictal epileptiform discharges (IED) and high frequency oscillations (HFO), with the intention to reduce brain hyperexcitability, thereby limiting seizure occurrence.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse event rateTime frame: Intervals through 7, 12, and 24 months post-implant
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Lucile Packard Children's Hospital Stanford
Palo Alto, California · Recruiting
Mayo Clinic
Rochester, Minnesota · Recruiting
Cook Children's Medical Center
Fort Worth, Texas · Recruiting
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.